Genmab — November 2024
-
*fremgår heller ikke (hvis nogen skulle være tvivl)
-
Johnson & Johnson to showcase strength of its broad hematology portfolio and pipeline at the 2024 American Society of Hematology Annual Meeting https://www.prnewswire.com/news-releases/johnson--johnson-to-showcase-strength-of-its-broad-hematology-portfolio-and-pipeline-at-the-2024-american-society-of-hematology-annual-meeting-302310074.html
-
What fanbase
-
@Lahn 1 - Det har, som jeg har læst det, hele tiden været meningen, at præsentationen først kunne tilgåes efter seancen
-
Iøvrigt må vi se lidt mere på de positive sider: Kursfaldet i Genmab påvirker kommende betaling af PAL skat meget positivt
-
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind